Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Proglumide (Binoside) is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 7,500 | |||
50 mg | 在庫あり | ¥ 11,000 | |||
100 mg | 在庫あり | ¥ 20,500 | |||
200 mg | 在庫あり | ¥ 28,000 | |||
500 mg | 在庫あり | ¥ 45,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 12,000 |
説明 | Proglumide (Binoside) is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers. |
分子量 | 334.41 |
分子式 | C18H26N2O4 |
CAS No. | 6620-60-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (164.47 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Proglumide 6620-60-6 GPCR/G Protein cholecystokinin SOD TBARS CCK-A CNS antiepileptic secretion CAT CCK Receptor CCK-B inhibit GSH Binoside Cholecystokinin Receptor GST antioxidant gastric Inhibitor Xylamide inhibitor